Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Association between histopathological alterations and diarrhea severity in acute intestinal graft-versus-host disease.

da Costa LNG, Costa-Lima C, de Meirelles LR, Carvalho RB, Colella MP, Aranha FJP, Vigorito AC, De Paula EV.

Medicine (Baltimore). 2018 May;97(19):e0600. doi: 10.1097/MD.0000000000010600.

2.

The correlation between preoperative levels of albumin and tlc and mortality in patients with femoral neck fracture.

Niccolai F, Parchi PD, Vigorito A, Pasqualetti G, Monzani F, Lisanti M.

J Biol Regul Homeost Agents. 2016 Oct-Dec;30(4 Suppl 1):187-191.

PMID:
28002918
3.

Acute and chronic Graft-versus-host disease after hematopoietic stem cell transplantation.

Funke VA, Moreira MC, Vigorito AC.

Rev Assoc Med Bras (1992). 2016 Oct;62 Suppl 1:44-50. Review.

4.

Regarding the torsional flexibility of the dihydrolipoic acid's pharmacophore: 1,3-propanedithiol.

Vigorito A, Calabrese C, Paltanin E, Melandri S, Maris A.

Phys Chem Chem Phys. 2016 Dec 21;19(1):496-502. doi: 10.1039/c6cp05606g.

PMID:
27905582
5.
6.

Translation, Cross-Cultural Adaptation, and Validation of the Lee Chronic Graft-versus-Host Disease Symptom Scale in a Brazilian Population.

Vasconcellos de Souza C, Vigorito AC, Miranda ECM, Garcia C Jr, Rensi Colturato VA, Mauad MA, Rodrigues Moreira MC, da Silva Bouzas LF, Lermontov S, Hamerschlak N, Rodrigues M, Carlos de Almeida Barros J, Chiattone R, Lee SJ, Flowers MED.

Biol Blood Marrow Transplant. 2016 Jul;22(7):1313-1318. doi: 10.1016/j.bbmt.2016.03.013. Epub 2016 Apr 4.

7.

Pretransplant β2-Microglobulin Is Associated with the Risk of Acute Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplant.

Costa-Lima C, Miranda ECM, Colella MP, Aranha FJP, de Souza CA, Vigorito AC, De Paula EV.

Biol Blood Marrow Transplant. 2016 Jul;22(7):1329-1332. doi: 10.1016/j.bbmt.2016.03.024. Epub 2016 Apr 1.

8.

Millimeter Wave Spectrum of the Weakly Bound Complex CH2═CHCN·H2O: Structure, Dynamics, and Implications for Astronomical Search.

Calabrese C, Vigorito A, Maris A, Mariotti S, Fathi P, Geppert WD, Melandri S.

J Phys Chem A. 2015 Dec 3;119(48):11674-82. doi: 10.1021/acs.jpca.5b08426. Epub 2015 Nov 20.

PMID:
26524193
9.

How CO2 Interacts with Carboxylic Acids: A Rotational Study of Formic Acid-CO2.

Vigorito A, Gou Q, Calabrese C, Melandri S, Maris A, Caminati W.

Chemphyschem. 2015 Oct 5;16(14):2961-7. doi: 10.1002/cphc.201500531.

PMID:
26247850
10.

Post-allogeneic Hematopoietic Stem Cell Transplantation (HSCT) changes in inorganic salivary components.

Boer CC, Correa ME, Tenuta LM, Souza CA, Vigorito AC.

Support Care Cancer. 2015 Sep;23(9):2561-7. doi: 10.1007/s00520-015-2613-0. Epub 2015 Feb 5.

PMID:
25652148
11.

Survival and graft-versus-host disease in patients receiving peripheral stem cell compared to bone marrow transplantation from HLA-matched related donor: retrospective analysis of 334 consecutive patients.

Campregher PV, Hamerschlak N, Colturato VA, Mauad MA, de Souza MP, Bouzas LF, Tavares Rde C, Barros JC, Chiattone R, Paz A, Silla L, Vigorito AC, Miranda E, Funke VA, Flowers ME.

Eur J Haematol. 2015 Nov;95(5):421-5. doi: 10.1111/ejh.12508. Epub 2015 Feb 19.

PMID:
25645430
12.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, Palmer J, Weisdorf D, Treister NS, Cheng GS, Kerr H, Stratton P, Duarte RF, McDonald GB, Inamoto Y, Vigorito A, Arai S, Datiles MB, Jacobsohn D, Heller T, Kitko CL, Mitchell SA, Martin PJ, Shulman H, Wu RS, Cutler CS, Vogelsang GB, Lee SJ, Pavletic SZ, Flowers ME.

Biol Blood Marrow Transplant. 2015 Mar;21(3):389-401.e1. doi: 10.1016/j.bbmt.2014.12.001. Epub 2014 Dec 18.

13.

Rhinosinusitis in hematopoietic stem cell-transplanted patients: influence of nasosinus mucosal abnormalities?

Ortiz E, Altemani A, Vigorito AC, Sakano E, Nicola EM.

Stem Cell Res Ther. 2014 Dec 4;5(6):133. doi: 10.1186/scrt523.

14.

Sinonasal disorders in hematopoietic stem cell transplantation.

Bento LR, Ortiz E, Nicola EM, Vigorito AC, Sakano E.

Braz J Otorhinolaryngol. 2014 Jul-Aug;80(4):285-9. doi: 10.1016/j.bjorl.2014.05.009. Epub 2014 Jun 11.

15.

Comparison of diagnostic tests in distinct well-defined conditions related to dry eye disease.

Alves M, Reinach PS, Paula JS, Vellasco e Cruz AA, Bachette L, Faustino J, Aranha FP, Vigorito A, de Souza CA, Rocha EM.

PLoS One. 2014 May 21;9(5):e97921. doi: 10.1371/journal.pone.0097921. eCollection 2014.

16.

A high angiopoietin-2/angiopoietin-1 ratio is associated with a high risk of septic shock in patients with febrile neutropenia.

Luz Fiusa MM, Costa-Lima C, de Souza GR, Vigorito AC, Penteado Aranha FJ, Lorand-Metze I, Annichino-Bizzacchi JM, de Souza CA, De Paula EV.

Crit Care. 2013 Aug 5;17(4):R169. doi: 10.1186/cc12848.

17.

Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation.

Dieamant DC, Bonon SH, Peres RM, Costa CR, Albuquerque DM, Miranda EC, Aranha FJ, Oliveira-Duarte G, Fernandes VC, De Souza CA, Costa SC, Vigorito AC.

BMC Infect Dis. 2013 Jul 10;13:310. doi: 10.1186/1471-2334-13-310.

18.

Quantifying loss of CD34+ cells collected by apheresis after processing for freezing and post-thaw.

Castelhano MV, Reis-Alves SC, Vigorito AC, Rocha FF, Pereira-Cunha FG, De Souza CA, Lorand-Metze I.

Transfus Apher Sci. 2013 Apr;48(2):241-6. doi: 10.1016/j.transci.2013.01.017. Epub 2013 Feb 6.

PMID:
23394728
19.

Adherence to tyrosine kinase inhibitor therapy for chronic myeloid leukemia: a Brazilian single-center cohort.

de Almeida MH, Pagnano KB, Vigorito AC, Lorand-Metze I, de Souza CA.

Acta Haematol. 2013;130(1):16-22. doi: 10.1159/000345722. Epub 2013 Jan 25.

PMID:
23363706
20.

Proton transfer in homodimers of carboxylic acids: the rotational spectrum of the dimer of acrylic acid.

Feng G, Favero LB, Maris A, Vigorito A, Caminati W, Meyer R.

J Am Chem Soc. 2012 Nov 21;134(46):19281-6. doi: 10.1021/ja309627m. Epub 2012 Nov 12.

PMID:
23127170
21.

Functional evaluation indicates physical losses after hematopoietic stem cell transplantation.

de Souza CV, Miranda EC, Garcia C Jr, Aranha FJ, de Souza CA, Vigorito AC.

Rev Bras Hematol Hemoter. 2012;34(5):345-51. doi: 10.5581/1516-8484.20120090.

22.

Association between human leukocyte antigens and graft-versus-host disease occurrence after allogenic hematopoietic stem cell transplantation.

Cardozo DM, Lieber SR, Marques SB, Aranha FJ, Vigorito AC, Souza CA, Visentainer JE.

Sao Paulo Med J. 2012;130(4):219-24.

23.

A multicenter feasibility study of chronic graft-versus-host disease according to the National Institute of Health criteria: efforts to establish a Brazil-Seattle consortium as a platform for future collaboration in clinical trials.

Vigorito AC, Bouzas LF, Moreira MC, Funke VA, Colturato VA, Pedro A, Souza CV, Nunes EC, Miranda EC, Camacho K, Mauad MA, Correa ME, Silva MD, Sousa MP, Tavares RD, Lee SJ, Flowers ME.

Rev Bras Hematol Hemoter. 2011;33(4):283-289.

24.

Histological features of the nasal mucosa in hematopoietic stem cell transplantation.

Ortiz E, Sakano E, Meirelles LR, Vigorito AC, Cintra ML, Paschoal IA, Chone CT.

Am J Rhinol Allergy. 2011 Sep-Oct;25(5):e191-5. doi: 10.2500/ajra.2011.25.3644.

PMID:
22186237
25.

Histological features of the nasal mucosa in hematopoietic stem cell transplantation.

Ortiz É, Sakano E, Meirelles LR, Vigorito AC, Cintra ML, Paschoal IA, Chone CT.

Am J Rhinol Allergy. 2011 Sep 1;25(5):191-195. doi: 10.2500/ajra.2011.25.3644.

PMID:
29021066
26.

Serological monitoring of a Toxoplasma infection after hematopoietic stem cell transplantation.

Rossi CL, Nascimento FS, de Barros-Mazon S, Dias DF, Vigorito AC, de Souza CA.

Rev Inst Med Trop Sao Paulo. 2010 Jul-Aug;52(4):225-7.

27.

Brazilian experience using high dose sequential chemotherapy followed by autologous hematopoietic stem cell transplantation for malignant lymphomas.

Duarte BK, Miranda EC, Nucci M, Vigorito AC, Penteado FJ, Marques JF Jr, Oliveira-Duarte GB, Lorand-Metze IG, Pagnano KB, Delamain MT, Baldissera R, Valente IS, de Souza CA.

Rev Bras Hematol Hemoter. 2011;33(6):432-8. doi: 10.5581/1516-8484.20110118.

28.

Brazilian workshop model to train investigators in chronic graft-versus-host disease clinical trials according to the 2005-2006 National Institutes of Health recommendations.

Tavares Rde C, Silva Mde M, Bouzas LF, Rodrigues MC, Vigorito AC, Funke V, Mauad M, Correa ME, de Souza CV, Nunes E, Ferrari A, Paixão A, Martins T, Pallottino E, Flowers ME.

Rev Bras Hematol Hemoter. 2011;33(5):358-66. doi: 10.5581/1516-8484.20110099.

29.

Monitoring of BCR-ABL levels in chronic myeloid leukemia patients treated with imatinib in the chronic phase - the importance of a major molecular response.

Machado MP, Tomaz JP, Lorand-Metze I, de Souza CA, Vigorito AC, Delamain MT, Bendit I, Pereira NF, Pagnano KB.

Rev Bras Hematol Hemoter. 2011;33(3):211-5. doi: 10.5581/1516-8484.20110056.

30.

Prognostic value of sinus CT scans in hematopoietic stem cell transplantation.

Ortiz E, Nakamura E, Magalhães R, Souza CA, Chone CT, Vigorito AC, Sakano E.

Braz J Otorhinolaryngol. 2010 Sep-Oct;76(5):618-22. English, Portuguese.

31.

Surveillance of active human cytomegalovirus infection in hematopoietic stem cell transplantation (HLA sibling identical donor): search for optimal cutoff value by real-time PCR.

Peres RM, Costa CR, Andrade PD, Bonon SH, Albuquerque DM, de Oliveira C, Vigorito AC, Aranha FJ, de Souza CA, Costa SC.

BMC Infect Dis. 2010 Jun 1;10:147. doi: 10.1186/1471-2334-10-147.

32.

Lung function and long-term complications after allogeneic hematopoietic cell transplant.

Walter EC, Orozco-Levi M, Ramirez-Sarmiento A, Vigorito A, Campregher PV, Martin PJ, Flowers ME, Chien JW.

Biol Blood Marrow Transplant. 2010 Jan;16(1):53-61. doi: 10.1016/j.bbmt.2009.08.016. Epub 2009 Oct 17.

33.

Brazilian experience using high-dose sequential chemotherapy followed by autologous hematopoietic stem cell transplantation for relapsed or refractory Hodgkin lymphoma.

Duarte BK, Valente I, Vigorito AC, Aranha FJ, Oliveira-Duarte G, Miranda EC, Lorand-Metze I, Pagnano KB, Delamain M, Marques Junior JF, Brandalise SR, Nucci M, De Souza CA.

Clin Lymphoma Myeloma. 2009 Dec;9(6):449-54. doi: 10.3816/CLM.2009.n.088.

PMID:
19951885
34.

Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD.

Vigorito AC, Campregher PV, Storer BE, Carpenter PA, Moravec CK, Kiem HP, Fero ML, Warren EH, Lee SJ, Appelbaum FR, Martin PJ, Flowers ME; National Institutes of Health.

Blood. 2009 Jul 16;114(3):702-8. doi: 10.1182/blood-2009-03-208983. Epub 2009 May 21.

35.

Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease.

Flowers ME, Storer B, Carpenter P, Rezvani AR, Vigorito AC, Campregher PV, Moravec C, Kiem HP, Fero M, Georges G, Warren E, Lee S, Sanders JE, Appelbaum F, Martin PJ.

Biol Blood Marrow Transplant. 2008 Dec;14(12):1380-4. doi: 10.1016/j.bbmt.2008.09.017.

36.

IL2 and TNFA gene polymorphisms and the risk of graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.

Viel DO, Tsuneto LT, Sossai CR, Lieber SR, Marques SB, Vigorito AC, Aranha FJ, de Brito Eid KA, Oliveira GB, Miranda EC, de Souza CA, Visentainer JE.

Scand J Immunol. 2007 Dec;66(6):703-10.

37.

[Association between HLA and leukemia in a mixed Brazilian population].

Barion LA, Tsuneto LT, Testa GV, Lieber SR, Persoli LB, Marques SB, Vigorito AC, Aranha FJ, Eid KA, Oliveira GB, Miranda EC, Souza CA, Visentainer JE.

Rev Assoc Med Bras (1992). 2007 May-Jun;53(3):252-6. Portuguese.

38.

Chronic GVHD: predictive factor for rhinosinusitis in bone marrow transplantation.

Ortiz E, Sakano E, De Souza CA, Vigorito A, Eid KA.

Braz J Otorhinolaryngol. 2006 May-Jun;72(3):328-32.

39.
40.

Risk factors and characteristics of ocular complications, and efficacy of autologous serum tears after haematopoietic progenitor cell transplantation.

Leite SC, de Castro RS, Alves M, Cunha DA, Correa ME, da Silveira LA, Vigorito AC, de Souza CA, Rocha EM.

Bone Marrow Transplant. 2006 Aug;38(3):223-7. Epub 2006 Jun 19.

PMID:
16785864
41.

Major salivary gland damage in allogeneic hematopoietic progenitor cell transplantation assessed by scintigraphic methods.

Coracin FL, Pizzigatti Correa ME, Camargo EE, Peterson DE, de Oliveira Santos A, Vigorito AC, Borba Oliveira G, de Brito Eid KA, Zulli R, De Souza CA.

Bone Marrow Transplant. 2006 May;37(10):955-9.

PMID:
16565740
42.

Frontline therapy with early intensification and autologous stem cell transplantation versus conventional chemotherapy in unselected high-risk, aggressive non-Hodgkin's lymphoma patients: a prospective randomized GEMOH report.

Baldissera RC, Nucci M, Vigorito AC, Maiolino A, Simões BP, Lorand-Metze I, Aranha FJ, Miranda EC, Pagnano KB, Ruiz MA, Moraes AA, De Souza CA.

Acta Haematol. 2006;115(1-2):15-21.

PMID:
16424644
43.

Primary oral and perioral amyloidosis associated with multiple myeloma.

Pereira CM, Gasparetto PF, Correa ME, Vigorito AC, de Almeida OP.

Gen Dent. 2005 Sep-Oct;53(5):340-1.

PMID:
16252537
44.

Evaluation of Fusarium solani hyphae and conidia susceptibility to amphotericin B and itraconazole: study of a clinical case.

Teixeira AB, Moretti ML, Trabasso P, von Nowakonski A, Aoki FH, Vigorito AC, Miyaji M, Nishimura K, Taguchi H, Schreiber AZ.

Mycopathologia. 2005 Nov;160(4):291-6.

PMID:
16244897
45.

Relationship between cytokine gene polymorphisms and graft-versus-host disease after allogeneic stem cell transplantation in a Brazilian population.

Laguila Visentainer JE, Lieber SR, Lopes Persoli LB, Dutra Marques SB, Vigorito AC, Penteado Aranha FJ, de Brito Eid KA, Oliveira GB, Martins Miranda EC, Bragotto L, de Souza CA.

Cytokine. 2005 Nov 3;32(3-4):171-7. Epub 2005 Oct 21.

PMID:
16243534
46.

Validation of the EBMT risk score in chronic myeloid leukemia in Brazil and allogeneic transplant outcome.

De Souza CA, Vigorito AC, Ruiz MA, Nucci M, Dulley FL, Funcke V, Tabak D, Azevedo AM, Byington R, Macedo MC, Saboya R, Penteado Aranha FJ, Oliveira GB, Zulli R, Martins Miranda EC, Azevedo WM, Lodi FM, Voltarelli JC, Simões BP, Colturato V, De Souza MP, Silla L, Bittencourt H, Piron-Ruiz L, Maiolino A, Gratwohl A, Pasquini R.

Haematologica. 2005 Feb;90(2):232-7.

47.

Surveillance of cytomegalovirus infection in haematopoietic stem cell transplantation patients.

Bonon SH, Menoni SM, Rossi CL, De Souza CA, Vigorito AC, Costa DB, Costa SC.

J Infect. 2005 Feb;50(2):130-7.

PMID:
15667914
48.

Infectious complications in patients randomized to receive allogeneic bone marrow or peripheral blood transplantation.

Nucci M, Andrade F, Vigorito A, Trabasso P, Aranha JF, Maiolino A, De Souza CA.

Transpl Infect Dis. 2003 Dec;5(4):167-73.

PMID:
14987200
49.

Phaeohyphomycosis caused by Chaetomium globosum in an allogeneic bone marrow transplant recipient.

Teixeira AB, Trabasso P, Moretti-Branchini ML, Aoki FH, Vigorito AC, Miyaji M, Mikami Y, Takada M, Schreiber AZ.

Mycopathologia. 2003;156(4):309-12.

PMID:
14682456
50.

Serum cytokine levels and acute graft-versus-host disease after HLA-identical hematopoietic stem cell transplantation.

Visentainer JE, Lieber SR, Persoli LB, Vigorito AC, Aranha FJ, de Brito Eid KA, Oliveira GB, Miranda EC, de Souza CA.

Exp Hematol. 2003 Nov;31(11):1044-50.

PMID:
14585368

Supplemental Content

Loading ...
Support Center